nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—SLC22A3—germ cell cancer	0.418	1	CbGaD
Lamivudine—ABCC1—Dactinomycin—germ cell cancer	0.0379	0.0926	CbGbCtD
Lamivudine—ABCC3—Cisplatin—germ cell cancer	0.0355	0.0866	CbGbCtD
Lamivudine—ABCC3—Etoposide—germ cell cancer	0.0349	0.0851	CbGbCtD
Lamivudine—ABCG2—Dactinomycin—germ cell cancer	0.0254	0.062	CbGbCtD
Lamivudine—ABCC1—Vinblastine—germ cell cancer	0.0238	0.058	CbGbCtD
Lamivudine—ABCC3—Methotrexate—germ cell cancer	0.023	0.0562	CbGbCtD
Lamivudine—SLC22A2—Vinblastine—germ cell cancer	0.0216	0.0526	CbGbCtD
Lamivudine—ABCC1—Etoposide—germ cell cancer	0.0214	0.0523	CbGbCtD
Lamivudine—SLC22A2—Cisplatin—germ cell cancer	0.0198	0.0482	CbGbCtD
Lamivudine—ABCC4—Methotrexate—germ cell cancer	0.0176	0.043	CbGbCtD
Lamivudine—ABCC2—Vinblastine—germ cell cancer	0.0176	0.0429	CbGbCtD
Lamivudine—ABCC2—Cisplatin—germ cell cancer	0.0161	0.0394	CbGbCtD
Lamivudine—ABCC2—Etoposide—germ cell cancer	0.0159	0.0387	CbGbCtD
Lamivudine—ABCG2—Cisplatin—germ cell cancer	0.0146	0.0356	CbGbCtD
Lamivudine—ABCG2—Etoposide—germ cell cancer	0.0143	0.035	CbGbCtD
Lamivudine—ABCC1—Methotrexate—germ cell cancer	0.0141	0.0345	CbGbCtD
Lamivudine—ABCC2—Methotrexate—germ cell cancer	0.0105	0.0256	CbGbCtD
Lamivudine—ABCG2—Methotrexate—germ cell cancer	0.00947	0.0231	CbGbCtD
Lamivudine—ABCB1—Dactinomycin—germ cell cancer	0.00916	0.0223	CbGbCtD
Lamivudine—SLC22A6—Methotrexate—germ cell cancer	0.00766	0.0187	CbGbCtD
Lamivudine—ABCB1—Vinblastine—germ cell cancer	0.00574	0.014	CbGbCtD
Lamivudine—ABCB1—Cisplatin—germ cell cancer	0.00526	0.0128	CbGbCtD
Lamivudine—ABCB1—Etoposide—germ cell cancer	0.00517	0.0126	CbGbCtD
Lamivudine—PGK1—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.00353	0.101	CbGpPWpGaD
Lamivudine—ABCB1—Methotrexate—germ cell cancer	0.00341	0.00833	CbGbCtD
Lamivudine—NME2—pineal body—germ cell cancer	0.00214	0.0337	CbGeAlD
Lamivudine—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00202	0.0577	CbGpPWpGaD
Lamivudine—SLC22A2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.002	0.0571	CbGpPWpGaD
Lamivudine—PGK1—Glycolysis and Gluconeogenesis—SLC2A3—germ cell cancer	0.00187	0.0533	CbGpPWpGaD
Lamivudine—SLC22A1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00186	0.0532	CbGpPWpGaD
Lamivudine—SLC22A2—Organic cation transport—SLC22A3—germ cell cancer	0.00137	0.0392	CbGpPWpGaD
Lamivudine—PGK1—brainstem—germ cell cancer	0.00134	0.0211	CbGeAlD
Lamivudine—SLC22A1—Organic cation transport—SLC22A3—germ cell cancer	0.00128	0.0365	CbGpPWpGaD
Lamivudine—NME1-NME2—eye—germ cell cancer	0.00119	0.0187	CbGeAlD
Lamivudine—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00116	0.0331	CbGpPWpGaD
Lamivudine—PCYT2—gonad—germ cell cancer	0.00115	0.0182	CbGeAlD
Lamivudine—SLC22A2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00115	0.0328	CbGpPWpGaD
Lamivudine—PGK1—skin of body—germ cell cancer	0.00113	0.0178	CbGeAlD
Lamivudine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00112	0.0319	CbGpPWpGaD
Lamivudine—NT5C—eye—germ cell cancer	0.0011	0.0173	CbGeAlD
Lamivudine—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00109	0.0312	CbGpPWpGaD
Lamivudine—SLC22A1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00107	0.0306	CbGpPWpGaD
Lamivudine—PGK1—gonad—germ cell cancer	0.00099	0.0156	CbGeAlD
Lamivudine—PGK1—uterus—germ cell cancer	0.000984	0.0155	CbGeAlD
Lamivudine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.000932	0.0266	CbGpPWpGaD
Lamivudine—NME1—neck—germ cell cancer	0.000927	0.0146	CbGeAlD
Lamivudine—PCYT2—endocrine gland—germ cell cancer	0.000871	0.0137	CbGeAlD
Lamivudine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.000868	0.0248	CbGpPWpGaD
Lamivudine—PCYT2—head—germ cell cancer	0.00086	0.0136	CbGeAlD
Lamivudine—PCYT2—testis—germ cell cancer	0.000831	0.0131	CbGeAlD
Lamivudine—NT5C—uterus—germ cell cancer	0.000831	0.0131	CbGeAlD
Lamivudine—NT5C—pituitary gland—germ cell cancer	0.000816	0.0129	CbGeAlD
Lamivudine—PCYT1A—gonad—germ cell cancer	0.000784	0.0124	CbGeAlD
Lamivudine—PGK1—endocrine gland—germ cell cancer	0.000748	0.0118	CbGeAlD
Lamivudine—PGK1—head—germ cell cancer	0.000739	0.0116	CbGeAlD
Lamivudine—NT5C—adrenal gland—germ cell cancer	0.000729	0.0115	CbGeAlD
Lamivudine—NME2—embryo—germ cell cancer	0.000728	0.0115	CbGeAlD
Lamivudine—PGK1—testis—germ cell cancer	0.000714	0.0112	CbGeAlD
Lamivudine—CMPK1—brainstem—germ cell cancer	0.000683	0.0108	CbGeAlD
Lamivudine—NME1-NME2—endocrine gland—germ cell cancer	0.000682	0.0107	CbGeAlD
Lamivudine—NT5C—female gonad—germ cell cancer	0.000679	0.0107	CbGeAlD
Lamivudine—NME1-NME2—head—germ cell cancer	0.000673	0.0106	CbGeAlD
Lamivudine—NME2—brainstem—germ cell cancer	0.000667	0.0105	CbGeAlD
Lamivudine—SLC22A1—ganglion—germ cell cancer	0.000667	0.0105	CbGeAlD
Lamivudine—PGK1—cerebellum—germ cell cancer	0.000659	0.0104	CbGeAlD
Lamivudine—NME2—eye—germ cell cancer	0.000649	0.0102	CbGeAlD
Lamivudine—NME2—retina—germ cell cancer	0.000644	0.0101	CbGeAlD
Lamivudine—NT5C—endocrine gland—germ cell cancer	0.000632	0.00996	CbGeAlD
Lamivudine—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000628	0.0179	CbGpPWpGaD
Lamivudine—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000625	0.0178	CbGpPWpGaD
Lamivudine—NT5C—head—germ cell cancer	0.000624	0.00983	CbGeAlD
Lamivudine—PCYT2—brain—germ cell cancer	0.000623	0.00982	CbGeAlD
Lamivudine—CMPK1—telencephalon—germ cell cancer	0.000606	0.00955	CbGeAlD
Lamivudine—NT5C—testis—germ cell cancer	0.000603	0.0095	CbGeAlD
Lamivudine—NME1—skin of body—germ cell cancer	0.0006	0.00945	CbGeAlD
Lamivudine—PCYT1A—endocrine gland—germ cell cancer	0.000593	0.00934	CbGeAlD
Lamivudine—PCYT1A—head—germ cell cancer	0.000585	0.00922	CbGeAlD
Lamivudine—CMPK1—skin of body—germ cell cancer	0.000578	0.00911	CbGeAlD
Lamivudine—CMPK1—decidua—germ cell cancer	0.000574	0.00905	CbGeAlD
Lamivudine—PCYT1A—testis—germ cell cancer	0.000565	0.00891	CbGeAlD
Lamivudine—NT5C—cerebellum—germ cell cancer	0.000557	0.00877	CbGeAlD
Lamivudine—PGK1—brain—germ cell cancer	0.000535	0.00844	CbGeAlD
Lamivudine—NME1—uterus—germ cell cancer	0.000521	0.00821	CbGeAlD
Lamivudine—CMPK1—gonad—germ cell cancer	0.000506	0.00797	CbGeAlD
Lamivudine—CMPK1—uterus—germ cell cancer	0.000502	0.00791	CbGeAlD
Lamivudine—PGK1—Carbohydrate metabolism—SLC2A3—germ cell cancer	0.000493	0.0141	CbGpPWpGaD
Lamivudine—CMPK1—pituitary gland—germ cell cancer	0.000493	0.00777	CbGeAlD
Lamivudine—NME1-NME2—lymph node—germ cell cancer	0.000471	0.00742	CbGeAlD
Lamivudine—SLC22A2—trigeminal ganglion—germ cell cancer	0.000464	0.00731	CbGeAlD
Lamivudine—NME1—adrenal gland—germ cell cancer	0.000457	0.0072	CbGeAlD
Lamivudine—NT5C—brain—germ cell cancer	0.000452	0.00712	CbGeAlD
Lamivudine—NME1—bone marrow—germ cell cancer	0.000442	0.00697	CbGeAlD
Lamivudine—CMPK1—adrenal gland—germ cell cancer	0.000441	0.00694	CbGeAlD
Lamivudine—NT5C—lymph node—germ cell cancer	0.000437	0.00688	CbGeAlD
Lamivudine—CMPK1—midbrain—germ cell cancer	0.000435	0.00686	CbGeAlD
Lamivudine—NME2—adrenal gland—germ cell cancer	0.000431	0.00679	CbGeAlD
Lamivudine—NME1—female gonad—germ cell cancer	0.000426	0.00672	CbGeAlD
Lamivudine—CMPK1—bone marrow—germ cell cancer	0.000426	0.00672	CbGeAlD
Lamivudine—CMPK1—spinal cord—germ cell cancer	0.000424	0.00669	CbGeAlD
Lamivudine—PCYT1A—brain—germ cell cancer	0.000424	0.00668	CbGeAlD
Lamivudine—CMPK1—female gonad—germ cell cancer	0.000411	0.00647	CbGeAlD
Lamivudine—NME2—female gonad—germ cell cancer	0.000402	0.00633	CbGeAlD
Lamivudine—NME1—endocrine gland—germ cell cancer	0.000396	0.00625	CbGeAlD
Lamivudine—NME1—head—germ cell cancer	0.000391	0.00617	CbGeAlD
Lamivudine—DCK—trigeminal ganglion—germ cell cancer	0.000384	0.00605	CbGeAlD
Lamivudine—CMPK1—endocrine gland—germ cell cancer	0.000382	0.00602	CbGeAlD
Lamivudine—NME1—testis—germ cell cancer	0.000378	0.00596	CbGeAlD
Lamivudine—CMPK1—head—germ cell cancer	0.000377	0.00594	CbGeAlD
Lamivudine—NME2—endocrine gland—germ cell cancer	0.000373	0.00589	CbGeAlD
Lamivudine—DCK—embryo—germ cell cancer	0.000371	0.00584	CbGeAlD
Lamivudine—NME2—head—germ cell cancer	0.000369	0.00581	CbGeAlD
Lamivudine—CMPK1—testis—germ cell cancer	0.000364	0.00574	CbGeAlD
Lamivudine—NME2—testis—germ cell cancer	0.000356	0.00561	CbGeAlD
Lamivudine—NME1—cerebellum—germ cell cancer	0.000349	0.0055	CbGeAlD
Lamivudine—CMPK1—cerebellum—germ cell cancer	0.000337	0.0053	CbGeAlD
Lamivudine—NME2—cerebellum—germ cell cancer	0.000329	0.00518	CbGeAlD
Lamivudine—DCK—retina—germ cell cancer	0.000328	0.00517	CbGeAlD
Lamivudine—SLC22A3—trigeminal ganglion—germ cell cancer	0.000313	0.00493	CbGeAlD
Lamivudine—SLC22A3—embryo—germ cell cancer	0.000302	0.00476	CbGeAlD
Lamivudine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000302	0.00862	CbGpPWpGaD
Lamivudine—DCK—telencephalon—germ cell cancer	0.000302	0.00475	CbGeAlD
Lamivudine—ABCC4—Platelet degranulation—CD9—germ cell cancer	0.000296	0.00843	CbGpPWpGaD
Lamivudine—DCK—decidua—germ cell cancer	0.000286	0.00451	CbGeAlD
Lamivudine—NME1—brain—germ cell cancer	0.000284	0.00447	CbGeAlD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.000282	0.00803	CbGpPWpGaD
Lamivudine—NME1—lymph node—germ cell cancer	0.000274	0.00432	CbGeAlD
Lamivudine—ABCC3—decidua—germ cell cancer	0.000274	0.00431	CbGeAlD
Lamivudine—CMPK1—brain—germ cell cancer	0.000273	0.00431	CbGeAlD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000268	0.00764	CbGpPWpGaD
Lamivudine—NME2—brain—germ cell cancer	0.000267	0.00421	CbGeAlD
Lamivudine—CMPK1—lymph node—germ cell cancer	0.000264	0.00416	CbGeAlD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000259	0.00738	CbGpPWpGaD
Lamivudine—NME2—lymph node—germ cell cancer	0.000258	0.00407	CbGeAlD
Lamivudine—SLC22A1—telencephalon—germ cell cancer	0.000257	0.00405	CbGeAlD
Lamivudine—DCK—gonad—germ cell cancer	0.000252	0.00397	CbGeAlD
Lamivudine—DCK—uterus—germ cell cancer	0.00025	0.00394	CbGeAlD
Lamivudine—DCK—pituitary gland—germ cell cancer	0.000246	0.00387	CbGeAlD
Lamivudine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.000237	0.00677	CbGpPWpGaD
Lamivudine—DCK—medulla oblongata—germ cell cancer	0.000237	0.00373	CbGeAlD
Lamivudine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000227	0.00648	CbGpPWpGaD
Lamivudine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000224	0.00639	CbGpPWpGaD
Lamivudine—DCK—adrenal gland—germ cell cancer	0.000219	0.00346	CbGeAlD
Lamivudine—DCK—midbrain—germ cell cancer	0.000217	0.00341	CbGeAlD
Lamivudine—ABCG2—trigeminal ganglion—germ cell cancer	0.000214	0.00338	CbGeAlD
Lamivudine—DCK—bone marrow—germ cell cancer	0.000212	0.00334	CbGeAlD
Lamivudine—DCK—spinal cord—germ cell cancer	0.000211	0.00333	CbGeAlD
Lamivudine—ABCC3—adrenal gland—germ cell cancer	0.00021	0.00331	CbGeAlD
Lamivudine—SLC22A3—gonad—germ cell cancer	0.000205	0.00323	CbGeAlD
Lamivudine—DCK—female gonad—germ cell cancer	0.000205	0.00322	CbGeAlD
Lamivudine—ABCC1—telencephalon—germ cell cancer	0.000203	0.0032	CbGeAlD
Lamivudine—ABCC3—NRF2 pathway—SLC2A3—germ cell cancer	0.0002	0.00571	CbGpPWpGaD
Lamivudine—ABCC4—uterus—germ cell cancer	0.000198	0.00311	CbGeAlD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000196	0.0056	CbGpPWpGaD
Lamivudine—ABCC3—female gonad—germ cell cancer	0.000196	0.00309	CbGeAlD
Lamivudine—ABCC1—decidua—germ cell cancer	0.000193	0.00304	CbGeAlD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—MYC—germ cell cancer	0.000192	0.00548	CbGpPWpGaD
Lamivudine—DCK—endocrine gland—germ cell cancer	0.00019	0.003	CbGeAlD
Lamivudine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000189	0.0054	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—SLC2A3—germ cell cancer	0.000188	0.00537	CbGpPWpGaD
Lamivudine—DCK—head—germ cell cancer	0.000188	0.00296	CbGeAlD
Lamivudine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000187	0.00532	CbGpPWpGaD
Lamivudine—ABCC3—endocrine gland—germ cell cancer	0.000182	0.00287	CbGeAlD
Lamivudine—DCK—testis—germ cell cancer	0.000181	0.00286	CbGeAlD
Lamivudine—ABCC3—head—germ cell cancer	0.00018	0.00283	CbGeAlD
Lamivudine—SLC22A3—adrenal gland—germ cell cancer	0.000179	0.00282	CbGeAlD
Lamivudine—SLC22A6—brain—germ cell cancer	0.000178	0.00281	CbGeAlD
Lamivudine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000177	0.00504	CbGpPWpGaD
Lamivudine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000174	0.00496	CbGpPWpGaD
Lamivudine—ABCC3—testis—germ cell cancer	0.000174	0.00274	CbGeAlD
Lamivudine—ABCC4—adrenal gland—germ cell cancer	0.000173	0.00273	CbGeAlD
Lamivudine—ABCB1—blood vessel—germ cell cancer	0.000171	0.0027	CbGeAlD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—germ cell cancer	0.00017	0.00486	CbGpPWpGaD
Lamivudine—ABCC1—uterus—germ cell cancer	0.000169	0.00266	CbGeAlD
Lamivudine—ABCG2—telencephalon—germ cell cancer	0.000168	0.00265	CbGeAlD
Lamivudine—ABCC2—adrenal gland—germ cell cancer	0.000168	0.00264	CbGeAlD
Lamivudine—ABCC4—bone marrow—germ cell cancer	0.000168	0.00264	CbGeAlD
Lamivudine—DCK—cerebellum—germ cell cancer	0.000168	0.00264	CbGeAlD
Lamivudine—SLC22A3—female gonad—germ cell cancer	0.000167	0.00263	CbGeAlD
Lamivudine—ABCC1—pituitary gland—germ cell cancer	0.000165	0.00261	CbGeAlD
Lamivudine—SLC22A1—endocrine gland—germ cell cancer	0.000162	0.00256	CbGeAlD
Lamivudine—ABCC4—female gonad—germ cell cancer	0.000162	0.00255	CbGeAlD
Lamivudine—SLC22A1—head—germ cell cancer	0.00016	0.00252	CbGeAlD
Lamivudine—ABCG2—decidua—germ cell cancer	0.000159	0.00251	CbGeAlD
Lamivudine—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	0.000159	0.00453	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—TP53—germ cell cancer	0.000158	0.0045	CbGpPWpGaD
Lamivudine—SLC22A3—endocrine gland—germ cell cancer	0.000155	0.00244	CbGeAlD
Lamivudine—ABCC4—Ectoderm Differentiation—SOX2—germ cell cancer	0.000154	0.00439	CbGpPWpGaD
Lamivudine—SLC22A3—head—germ cell cancer	0.000153	0.00241	CbGeAlD
Lamivudine—ABCC4—endocrine gland—germ cell cancer	0.00015	0.00237	CbGeAlD
Lamivudine—ABCC4—head—germ cell cancer	0.000148	0.00234	CbGeAlD
Lamivudine—SLC22A3—testis—germ cell cancer	0.000148	0.00233	CbGeAlD
Lamivudine—ABCC1—adrenal gland—germ cell cancer	0.000148	0.00233	CbGeAlD
Lamivudine—Hypoaesthesia—Etoposide—germ cell cancer	0.000147	0.00199	CcSEcCtD
Lamivudine—Malaise—Ifosfamide—germ cell cancer	0.000147	0.00199	CcSEcCtD
Lamivudine—Vertigo—Ifosfamide—germ cell cancer	0.000146	0.00198	CcSEcCtD
Lamivudine—Leukopenia—Ifosfamide—germ cell cancer	0.000146	0.00198	CcSEcCtD
Lamivudine—Polyuria—Methotrexate—germ cell cancer	0.000146	0.00198	CcSEcCtD
Lamivudine—Immune system disorder—Cisplatin—germ cell cancer	0.000146	0.00198	CcSEcCtD
Lamivudine—Abdominal pain—Vinblastine—germ cell cancer	0.000146	0.00197	CcSEcCtD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—MYC—germ cell cancer	0.000146	0.00415	CbGpPWpGaD
Lamivudine—ABCC2—endocrine gland—germ cell cancer	0.000146	0.00229	CbGeAlD
Lamivudine—Mediastinal disorder—Cisplatin—germ cell cancer	0.000145	0.00197	CcSEcCtD
Lamivudine—Hypotension—Bleomycin—germ cell cancer	0.000145	0.00197	CcSEcCtD
Lamivudine—Oedema—Dactinomycin—germ cell cancer	0.000145	0.00197	CcSEcCtD
Lamivudine—Infection—Dactinomycin—germ cell cancer	0.000144	0.00195	CcSEcCtD
Lamivudine—NT5C—Metabolism—SLC2A3—germ cell cancer	0.000144	0.0041	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—SLC2A3—germ cell cancer	0.000144	0.0041	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—SLC2A3—germ cell cancer	0.000144	0.0041	CbGpPWpGaD
Lamivudine—ABCC4—testis—germ cell cancer	0.000143	0.00226	CbGeAlD
Lamivudine—Alopecia—Cisplatin—germ cell cancer	0.000143	0.00193	CcSEcCtD
Lamivudine—Cough—Ifosfamide—germ cell cancer	0.000142	0.00193	CcSEcCtD
Lamivudine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000142	0.00193	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000142	0.00192	CcSEcCtD
Lamivudine—PCYT2—Metabolism—SLC22A3—germ cell cancer	0.000141	0.00403	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—SLC22A3—germ cell cancer	0.000141	0.00403	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—SLC22A3—germ cell cancer	0.000141	0.00403	CbGpPWpGaD
Lamivudine—Convulsion—Ifosfamide—germ cell cancer	0.000141	0.00191	CcSEcCtD
Lamivudine—Malnutrition—Cisplatin—germ cell cancer	0.00014	0.0019	CcSEcCtD
Lamivudine—Erythema—Cisplatin—germ cell cancer	0.00014	0.0019	CcSEcCtD
Lamivudine—Erythema multiforme—Etoposide—germ cell cancer	0.00014	0.00189	CcSEcCtD
Lamivudine—PGK1—Disease—SLC2A3—germ cell cancer	0.00014	0.00399	CbGpPWpGaD
Lamivudine—Paraesthesia—Bleomycin—germ cell cancer	0.00014	0.00189	CcSEcCtD
Lamivudine—ABCG2—uterus—germ cell cancer	0.00014	0.0022	CbGeAlD
Lamivudine—ABCC2—testis—germ cell cancer	0.000139	0.00219	CbGeAlD
Lamivudine—Dyspnoea—Bleomycin—germ cell cancer	0.000139	0.00188	CcSEcCtD
Lamivudine—Chest pain—Ifosfamide—germ cell cancer	0.000139	0.00188	CcSEcCtD
Lamivudine—Arthralgia—Ifosfamide—germ cell cancer	0.000139	0.00188	CcSEcCtD
Lamivudine—Myalgia—Ifosfamide—germ cell cancer	0.000139	0.00188	CcSEcCtD
Lamivudine—Flatulence—Cisplatin—germ cell cancer	0.000138	0.00188	CcSEcCtD
Lamivudine—Anorexia—Dactinomycin—germ cell cancer	0.000138	0.00187	CcSEcCtD
Lamivudine—ABCC1—female gonad—germ cell cancer	0.000138	0.00217	CbGeAlD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000138	0.00187	CcSEcCtD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000137	0.00392	CbGpPWpGaD
Lamivudine—Discomfort—Ifosfamide—germ cell cancer	0.000137	0.00186	CcSEcCtD
Lamivudine—ABCG2—pituitary gland—germ cell cancer	0.000137	0.00216	CbGeAlD
Lamivudine—DCK—brain—germ cell cancer	0.000136	0.00214	CbGeAlD
Lamivudine—Hypersensitivity—Vinblastine—germ cell cancer	0.000136	0.00184	CcSEcCtD
Lamivudine—Decreased appetite—Bleomycin—germ cell cancer	0.000135	0.00183	CcSEcCtD
Lamivudine—Muscle spasms—Cisplatin—germ cell cancer	0.000135	0.00183	CcSEcCtD
Lamivudine—Confusional state—Ifosfamide—germ cell cancer	0.000134	0.00182	CcSEcCtD
Lamivudine—Immune system disorder—Etoposide—germ cell cancer	0.000134	0.00181	CcSEcCtD
Lamivudine—Mediastinal disorder—Etoposide—germ cell cancer	0.000133	0.00181	CcSEcCtD
Lamivudine—Pain—Bleomycin—germ cell cancer	0.000133	0.0018	CcSEcCtD
Lamivudine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000133	0.0018	CcSEcCtD
Lamivudine—Oedema—Ifosfamide—germ cell cancer	0.000133	0.0018	CcSEcCtD
Lamivudine—Chills—Etoposide—germ cell cancer	0.000133	0.0018	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000132	0.00179	CcSEcCtD
Lamivudine—ABCG2—medulla oblongata—germ cell cancer	0.000132	0.00208	CbGeAlD
Lamivudine—Asthenia—Vinblastine—germ cell cancer	0.000132	0.00179	CcSEcCtD
Lamivudine—Infection—Ifosfamide—germ cell cancer	0.000132	0.00179	CcSEcCtD
Lamivudine—Tremor—Cisplatin—germ cell cancer	0.000132	0.00178	CcSEcCtD
Lamivudine—DCK—lymph node—germ cell cancer	0.000132	0.00207	CbGeAlD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000131	0.00374	CbGpPWpGaD
Lamivudine—Alopecia—Etoposide—germ cell cancer	0.000131	0.00177	CcSEcCtD
Lamivudine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00013	0.00177	CcSEcCtD
Lamivudine—Ill-defined disorder—Cisplatin—germ cell cancer	0.00013	0.00177	CcSEcCtD
Lamivudine—ABCC3—brain—germ cell cancer	0.00013	0.00205	CbGeAlD
Lamivudine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00013	0.00176	CcSEcCtD
Lamivudine—Anaemia—Cisplatin—germ cell cancer	0.00013	0.00176	CcSEcCtD
Lamivudine—Skin disorder—Ifosfamide—germ cell cancer	0.000129	0.00175	CcSEcCtD
Lamivudine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000129	0.00174	CcSEcCtD
Lamivudine—Feeling abnormal—Bleomycin—germ cell cancer	0.000128	0.00174	CcSEcCtD
Lamivudine—Anorexia—Ifosfamide—germ cell cancer	0.000127	0.00172	CcSEcCtD
Lamivudine—Malaise—Cisplatin—germ cell cancer	0.000127	0.00172	CcSEcCtD
Lamivudine—Decreased appetite—Dactinomycin—germ cell cancer	0.000126	0.00171	CcSEcCtD
Lamivudine—Diarrhoea—Vinblastine—germ cell cancer	0.000126	0.00171	CcSEcCtD
Lamivudine—Dysgeusia—Etoposide—germ cell cancer	0.000126	0.00171	CcSEcCtD
Lamivudine—ABCC3—lymph node—germ cell cancer	0.000126	0.00198	CbGeAlD
Lamivudine—Leukopenia—Cisplatin—germ cell cancer	0.000126	0.0017	CcSEcCtD
Lamivudine—Fatigue—Dactinomycin—germ cell cancer	0.000125	0.0017	CcSEcCtD
Lamivudine—Back pain—Etoposide—germ cell cancer	0.000124	0.00169	CcSEcCtD
Lamivudine—Hypotension—Ifosfamide—germ cell cancer	0.000124	0.00168	CcSEcCtD
Lamivudine—Pain—Dactinomycin—germ cell cancer	0.000124	0.00168	CcSEcCtD
Lamivudine—Muscle spasms—Etoposide—germ cell cancer	0.000124	0.00168	CcSEcCtD
Lamivudine—Urticaria—Bleomycin—germ cell cancer	0.000124	0.00168	CcSEcCtD
Lamivudine—Body temperature increased—Bleomycin—germ cell cancer	0.000123	0.00167	CcSEcCtD
Lamivudine—ABCG2—adrenal gland—germ cell cancer	0.000122	0.00193	CbGeAlD
Lamivudine—ABCC1—testis—germ cell cancer	0.000122	0.00193	CbGeAlD
Lamivudine—Dizziness—Vinblastine—germ cell cancer	0.000122	0.00165	CcSEcCtD
Lamivudine—Convulsion—Cisplatin—germ cell cancer	0.000122	0.00165	CcSEcCtD
Lamivudine—Mood swings—Methotrexate—germ cell cancer	0.000121	0.00164	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000121	0.00164	CcSEcCtD
Lamivudine—ABCG2—midbrain—germ cell cancer	0.000121	0.0019	CbGeAlD
Lamivudine—Myalgia—Cisplatin—germ cell cancer	0.00012	0.00162	CcSEcCtD
Lamivudine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00012	0.00162	CcSEcCtD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—TP53—germ cell cancer	0.00012	0.00341	CbGpPWpGaD
Lamivudine—Paraesthesia—Ifosfamide—germ cell cancer	0.000119	0.00162	CcSEcCtD
Lamivudine—Ill-defined disorder—Etoposide—germ cell cancer	0.000119	0.00162	CcSEcCtD
Lamivudine—Anxiety—Cisplatin—germ cell cancer	0.000119	0.00162	CcSEcCtD
Lamivudine—Anaemia—Etoposide—germ cell cancer	0.000119	0.00161	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000119	0.00161	CcSEcCtD
Lamivudine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000119	0.00161	CcSEcCtD
Lamivudine—Dyspnoea—Ifosfamide—germ cell cancer	0.000119	0.00161	CcSEcCtD
Lamivudine—ABCG2—bone marrow—germ cell cancer	0.000118	0.00187	CbGeAlD
Lamivudine—Somnolence—Ifosfamide—germ cell cancer	0.000118	0.0016	CcSEcCtD
Lamivudine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000118	0.0016	CcSEcCtD
Lamivudine—Discomfort—Cisplatin—germ cell cancer	0.000118	0.0016	CcSEcCtD
Lamivudine—ABCG2—spinal cord—germ cell cancer	0.000118	0.00186	CbGeAlD
Lamivudine—Vomiting—Vinblastine—germ cell cancer	0.000117	0.00159	CcSEcCtD
Lamivudine—PGK1—Metabolism—SLC2A3—germ cell cancer	0.000117	0.00334	CbGpPWpGaD
Lamivudine—SLC22A1—brain—germ cell cancer	0.000116	0.00183	CbGeAlD
Lamivudine—Malaise—Etoposide—germ cell cancer	0.000116	0.00157	CcSEcCtD
Lamivudine—Vertigo—Etoposide—germ cell cancer	0.000116	0.00157	CcSEcCtD
Lamivudine—Decreased appetite—Ifosfamide—germ cell cancer	0.000116	0.00157	CcSEcCtD
Lamivudine—Headache—Vinblastine—germ cell cancer	0.000115	0.00156	CcSEcCtD
Lamivudine—NT5C—Metabolism—CRABP1—germ cell cancer	0.000115	0.00329	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CRABP1—germ cell cancer	0.000115	0.00329	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—CRABP1—germ cell cancer	0.000115	0.00329	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—SLC22A3—germ cell cancer	0.000115	0.00329	CbGpPWpGaD
Lamivudine—Leukopenia—Etoposide—germ cell cancer	0.000115	0.00156	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000115	0.00156	CcSEcCtD
Lamivudine—Abdominal pain—Dactinomycin—germ cell cancer	0.000115	0.00155	CcSEcCtD
Lamivudine—Body temperature increased—Dactinomycin—germ cell cancer	0.000115	0.00155	CcSEcCtD
Lamivudine—Fatigue—Ifosfamide—germ cell cancer	0.000115	0.00155	CcSEcCtD
Lamivudine—Oedema—Cisplatin—germ cell cancer	0.000115	0.00155	CcSEcCtD
Lamivudine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000115	0.00155	CcSEcCtD
Lamivudine—Hypersensitivity—Bleomycin—germ cell cancer	0.000115	0.00155	CcSEcCtD
Lamivudine—ABCG2—female gonad—germ cell cancer	0.000114	0.0018	CbGeAlD
Lamivudine—Infection—Cisplatin—germ cell cancer	0.000114	0.00154	CcSEcCtD
Lamivudine—Pain—Ifosfamide—germ cell cancer	0.000114	0.00154	CcSEcCtD
Lamivudine—Constipation—Ifosfamide—germ cell cancer	0.000114	0.00154	CcSEcCtD
Lamivudine—Loss of consciousness—Etoposide—germ cell cancer	0.000113	0.00153	CcSEcCtD
Lamivudine—ABCC1—cerebellum—germ cell cancer	0.000113	0.00178	CbGeAlD
Lamivudine—Nervous system disorder—Cisplatin—germ cell cancer	0.000112	0.00152	CcSEcCtD
Lamivudine—Cough—Etoposide—germ cell cancer	0.000112	0.00152	CcSEcCtD
Lamivudine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000112	0.00152	CcSEcCtD
Lamivudine—Asthenia—Bleomycin—germ cell cancer	0.000112	0.00151	CcSEcCtD
Lamivudine—Convulsion—Etoposide—germ cell cancer	0.000112	0.00151	CcSEcCtD
Lamivudine—Skin disorder—Cisplatin—germ cell cancer	0.000111	0.00151	CcSEcCtD
Lamivudine—SLC22A3—brain—germ cell cancer	0.000111	0.00175	CbGeAlD
Lamivudine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000111	0.0015	CcSEcCtD
Lamivudine—Pruritus—Bleomycin—germ cell cancer	0.00011	0.00149	CcSEcCtD
Lamivudine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00011	0.00149	CcSEcCtD
Lamivudine—Chest pain—Etoposide—germ cell cancer	0.00011	0.00148	CcSEcCtD
Lamivudine—Nausea—Vinblastine—germ cell cancer	0.000109	0.00148	CcSEcCtD
Lamivudine—Anorexia—Cisplatin—germ cell cancer	0.000109	0.00148	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—SLC2A3—germ cell cancer	0.000109	0.0031	CbGpPWpGaD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000109	0.00147	CcSEcCtD
Lamivudine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000109	0.00147	CcSEcCtD
Lamivudine—Pancreatitis—Methotrexate—germ cell cancer	0.000108	0.00147	CcSEcCtD
Lamivudine—Discomfort—Etoposide—germ cell cancer	0.000108	0.00147	CcSEcCtD
Lamivudine—ABCC4—brain—germ cell cancer	0.000108	0.0017	CbGeAlD
Lamivudine—SLC22A3—lymph node—germ cell cancer	0.000107	0.00169	CbGeAlD
Lamivudine—PCYT1A—Metabolism—SLC22A3—germ cell cancer	0.000107	0.00306	CbGpPWpGaD
Lamivudine—Hypotension—Cisplatin—germ cell cancer	0.000107	0.00145	CcSEcCtD
Lamivudine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000107	0.00145	CcSEcCtD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000107	0.00304	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000106	0.00304	CbGpPWpGaD
Lamivudine—Abdominal discomfort—Methotrexate—germ cell cancer	0.000106	0.00144	CcSEcCtD
Lamivudine—Confusional state—Etoposide—germ cell cancer	0.000106	0.00144	CcSEcCtD
Lamivudine—ABCB1—trigeminal ganglion—germ cell cancer	0.000106	0.00167	CbGeAlD
Lamivudine—Urticaria—Ifosfamide—germ cell cancer	0.000106	0.00143	CcSEcCtD
Lamivudine—Abdominal pain—Ifosfamide—germ cell cancer	0.000105	0.00142	CcSEcCtD
Lamivudine—Body temperature increased—Ifosfamide—germ cell cancer	0.000105	0.00142	CcSEcCtD
Lamivudine—Pancytopenia—Methotrexate—germ cell cancer	0.000105	0.00142	CcSEcCtD
Lamivudine—Anaphylactic shock—Etoposide—germ cell cancer	0.000105	0.00142	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000104	0.00142	CcSEcCtD
Lamivudine—Infection—Etoposide—germ cell cancer	0.000104	0.00141	CcSEcCtD
Lamivudine—Asthenia—Dactinomycin—germ cell cancer	0.000104	0.00141	CcSEcCtD
Lamivudine—ABCC4—lymph node—germ cell cancer	0.000104	0.00164	CbGeAlD
Lamivudine—Dysuria—Methotrexate—germ cell cancer	0.000103	0.0014	CcSEcCtD
Lamivudine—Neutropenia—Methotrexate—germ cell cancer	0.000103	0.0014	CcSEcCtD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000103	0.00295	CbGpPWpGaD
Lamivudine—Paraesthesia—Cisplatin—germ cell cancer	0.000103	0.0014	CcSEcCtD
Lamivudine—Thrombocytopenia—Etoposide—germ cell cancer	0.000103	0.00139	CcSEcCtD
Lamivudine—Dyspnoea—Cisplatin—germ cell cancer	0.000102	0.00139	CcSEcCtD
Lamivudine—ABCB1—embryo—germ cell cancer	0.000102	0.00161	CbGeAlD
Lamivudine—Skin disorder—Etoposide—germ cell cancer	0.000102	0.00138	CcSEcCtD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000102	0.0029	CbGpPWpGaD
Lamivudine—Hyperhidrosis—Etoposide—germ cell cancer	0.000102	0.00138	CcSEcCtD
Lamivudine—ABCG2—testis—germ cell cancer	0.000101	0.0016	CbGeAlD
Lamivudine—ABCC2—lymph node—germ cell cancer	0.000101	0.00159	CbGeAlD
Lamivudine—Anorexia—Etoposide—germ cell cancer	0.0001	0.00136	CcSEcCtD
Lamivudine—Decreased appetite—Cisplatin—germ cell cancer	9.97e-05	0.00135	CcSEcCtD
Lamivudine—NME2—Metabolism—SLC2A3—germ cell cancer	9.95e-05	0.00284	CbGpPWpGaD
Lamivudine—Diarrhoea—Dactinomycin—germ cell cancer	9.93e-05	0.00135	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Cisplatin—germ cell cancer	9.9e-05	0.00134	CcSEcCtD
Lamivudine—Vomiting—Bleomycin—germ cell cancer	9.89e-05	0.00134	CcSEcCtD
Lamivudine—Depression—Methotrexate—germ cell cancer	9.84e-05	0.00133	CcSEcCtD
Lamivudine—Hypotension—Etoposide—germ cell cancer	9.81e-05	0.00133	CcSEcCtD
Lamivudine—Rash—Bleomycin—germ cell cancer	9.81e-05	0.00133	CcSEcCtD
Lamivudine—Pain—Cisplatin—germ cell cancer	9.8e-05	0.00133	CcSEcCtD
Lamivudine—NME2—Metabolism—SLC22A3—germ cell cancer	9.8e-05	0.0028	CbGpPWpGaD
Lamivudine—Dermatitis—Bleomycin—germ cell cancer	9.8e-05	0.00133	CcSEcCtD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.8e-05	0.0028	CbGpPWpGaD
Lamivudine—Hypersensitivity—Ifosfamide—germ cell cancer	9.8e-05	0.00133	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	9.78e-05	0.00133	CcSEcCtD
Lamivudine—Renal failure—Methotrexate—germ cell cancer	9.7e-05	0.00131	CcSEcCtD
Lamivudine—Stomatitis—Methotrexate—germ cell cancer	9.61e-05	0.0013	CcSEcCtD
Lamivudine—ABCC3—Fluoropyrimidine Activity—TP53—germ cell cancer	9.57e-05	0.00273	CbGpPWpGaD
Lamivudine—Asthenia—Ifosfamide—germ cell cancer	9.54e-05	0.00129	CcSEcCtD
Lamivudine—Sweating—Methotrexate—germ cell cancer	9.46e-05	0.00128	CcSEcCtD
Lamivudine—Feeling abnormal—Cisplatin—germ cell cancer	9.45e-05	0.00128	CcSEcCtD
Lamivudine—Paraesthesia—Etoposide—germ cell cancer	9.43e-05	0.00128	CcSEcCtD
Lamivudine—Pruritus—Ifosfamide—germ cell cancer	9.41e-05	0.00127	CcSEcCtD
Lamivudine—PGK1—Metabolism—CRABP1—germ cell cancer	9.4e-05	0.00268	CbGpPWpGaD
Lamivudine—Dyspnoea—Etoposide—germ cell cancer	9.36e-05	0.00127	CcSEcCtD
Lamivudine—ABCG2—cerebellum—germ cell cancer	9.35e-05	0.00147	CbGeAlD
Lamivudine—Somnolence—Etoposide—germ cell cancer	9.34e-05	0.00127	CcSEcCtD
Lamivudine—Hepatobiliary disease—Methotrexate—germ cell cancer	9.33e-05	0.00126	CcSEcCtD
Lamivudine—Epistaxis—Methotrexate—germ cell cancer	9.3e-05	0.00126	CcSEcCtD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	9.25e-05	0.00264	CbGpPWpGaD
Lamivudine—Nausea—Bleomycin—germ cell cancer	9.24e-05	0.00125	CcSEcCtD
Lamivudine—Vomiting—Dactinomycin—germ cell cancer	9.23e-05	0.00125	CcSEcCtD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.21e-05	0.00263	CbGpPWpGaD
Lamivudine—Agranulocytosis—Methotrexate—germ cell cancer	9.21e-05	0.00125	CcSEcCtD
Lamivudine—ABCC1—brain—germ cell cancer	9.17e-05	0.00145	CbGeAlD
Lamivudine—Rash—Dactinomycin—germ cell cancer	9.15e-05	0.00124	CcSEcCtD
Lamivudine—Decreased appetite—Etoposide—germ cell cancer	9.13e-05	0.00124	CcSEcCtD
Lamivudine—Diarrhoea—Ifosfamide—germ cell cancer	9.1e-05	0.00123	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Etoposide—germ cell cancer	9.07e-05	0.00123	CcSEcCtD
Lamivudine—Body temperature increased—Cisplatin—germ cell cancer	9.06e-05	0.00123	CcSEcCtD
Lamivudine—Fatigue—Etoposide—germ cell cancer	9.06e-05	0.00123	CcSEcCtD
Lamivudine—ABCB1—retina—germ cell cancer	9.02e-05	0.00142	CbGeAlD
Lamivudine—ABCC4—Fluoropyrimidine Activity—TP53—germ cell cancer	9e-05	0.00257	CbGpPWpGaD
Lamivudine—Pain—Etoposide—germ cell cancer	8.98e-05	0.00122	CcSEcCtD
Lamivudine—Constipation—Etoposide—germ cell cancer	8.98e-05	0.00122	CcSEcCtD
Lamivudine—ABCC1—lymph node—germ cell cancer	8.86e-05	0.0014	CbGeAlD
Lamivudine—Hepatitis—Methotrexate—germ cell cancer	8.85e-05	0.0012	CcSEcCtD
Lamivudine—Dizziness—Ifosfamide—germ cell cancer	8.79e-05	0.00119	CcSEcCtD
Lamivudine—Pharyngitis—Methotrexate—germ cell cancer	8.79e-05	0.00119	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—CRABP1—germ cell cancer	8.74e-05	0.00249	CbGpPWpGaD
Lamivudine—Feeling abnormal—Etoposide—germ cell cancer	8.65e-05	0.00117	CcSEcCtD
Lamivudine—Nausea—Dactinomycin—germ cell cancer	8.62e-05	0.00117	CcSEcCtD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	8.61e-05	0.00246	CbGpPWpGaD
Lamivudine—Gastrointestinal pain—Etoposide—germ cell cancer	8.59e-05	0.00116	CcSEcCtD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	8.48e-05	0.00242	CbGpPWpGaD
Lamivudine—Vomiting—Ifosfamide—germ cell cancer	8.46e-05	0.00115	CcSEcCtD
Lamivudine—Hypersensitivity—Cisplatin—germ cell cancer	8.45e-05	0.00114	CcSEcCtD
Lamivudine—Rash—Ifosfamide—germ cell cancer	8.38e-05	0.00114	CcSEcCtD
Lamivudine—Dermatitis—Ifosfamide—germ cell cancer	8.38e-05	0.00114	CcSEcCtD
Lamivudine—Erythema multiforme—Methotrexate—germ cell cancer	8.37e-05	0.00113	CcSEcCtD
Lamivudine—Urticaria—Etoposide—germ cell cancer	8.34e-05	0.00113	CcSEcCtD
Lamivudine—Abdominal pain—Etoposide—germ cell cancer	8.3e-05	0.00113	CcSEcCtD
Lamivudine—Body temperature increased—Etoposide—germ cell cancer	8.3e-05	0.00113	CcSEcCtD
Lamivudine—ABCB1—telencephalon—germ cell cancer	8.3e-05	0.00131	CbGeAlD
Lamivudine—Asthenia—Cisplatin—germ cell cancer	8.23e-05	0.00111	CcSEcCtD
Lamivudine—PGK1—Disease—FGF4—germ cell cancer	8.03e-05	0.00229	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	8.02e-05	0.00229	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.02e-05	0.00229	CbGpPWpGaD
Lamivudine—Immune system disorder—Methotrexate—germ cell cancer	8e-05	0.00108	CcSEcCtD
Lamivudine—NME2—Metabolism—CRABP1—germ cell cancer	7.99e-05	0.00228	CbGpPWpGaD
Lamivudine—Mediastinal disorder—Methotrexate—germ cell cancer	7.98e-05	0.00108	CcSEcCtD
Lamivudine—Chills—Methotrexate—germ cell cancer	7.95e-05	0.00108	CcSEcCtD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	7.9e-05	0.00225	CbGpPWpGaD
Lamivudine—Nausea—Ifosfamide—germ cell cancer	7.9e-05	0.00107	CcSEcCtD
Lamivudine—ABCB1—decidua—germ cell cancer	7.86e-05	0.00124	CbGeAlD
Lamivudine—Diarrhoea—Cisplatin—germ cell cancer	7.84e-05	0.00106	CcSEcCtD
Lamivudine—Alopecia—Methotrexate—germ cell cancer	7.82e-05	0.00106	CcSEcCtD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.77e-05	0.00222	CbGpPWpGaD
Lamivudine—Hypersensitivity—Etoposide—germ cell cancer	7.74e-05	0.00105	CcSEcCtD
Lamivudine—Erythema—Methotrexate—germ cell cancer	7.71e-05	0.00104	CcSEcCtD
Lamivudine—Malnutrition—Methotrexate—germ cell cancer	7.71e-05	0.00104	CcSEcCtD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.68e-05	0.00219	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	7.59e-05	0.00217	CbGpPWpGaD
Lamivudine—ABCG2—brain—germ cell cancer	7.59e-05	0.0012	CbGeAlD
Lamivudine—Dysgeusia—Methotrexate—germ cell cancer	7.55e-05	0.00102	CcSEcCtD
Lamivudine—NME1—Metabolism—SLC2A3—germ cell cancer	7.54e-05	0.00215	CbGpPWpGaD
Lamivudine—Asthenia—Etoposide—germ cell cancer	7.54e-05	0.00102	CcSEcCtD
Lamivudine—Back pain—Methotrexate—germ cell cancer	7.46e-05	0.00101	CcSEcCtD
Lamivudine—Pruritus—Etoposide—germ cell cancer	7.43e-05	0.00101	CcSEcCtD
Lamivudine—NME1—Metabolism—SLC22A3—germ cell cancer	7.43e-05	0.00212	CbGpPWpGaD
Lamivudine—ABCG2—lymph node—germ cell cancer	7.34e-05	0.00116	CbGeAlD
Lamivudine—Vomiting—Cisplatin—germ cell cancer	7.29e-05	0.000988	CcSEcCtD
Lamivudine—Rash—Cisplatin—germ cell cancer	7.23e-05	0.00098	CcSEcCtD
Lamivudine—Dermatitis—Cisplatin—germ cell cancer	7.22e-05	0.000979	CcSEcCtD
Lamivudine—Diarrhoea—Etoposide—germ cell cancer	7.19e-05	0.000974	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	7.19e-05	0.00205	CbGpPWpGaD
Lamivudine—PGK1—Disease—H2AFZ—germ cell cancer	7.17e-05	0.00204	CbGpPWpGaD
Lamivudine—Ill-defined disorder—Methotrexate—germ cell cancer	7.15e-05	0.000969	CcSEcCtD
Lamivudine—Anaemia—Methotrexate—germ cell cancer	7.12e-05	0.000966	CcSEcCtD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.97e-05	0.00199	CbGpPWpGaD
Lamivudine—Malaise—Methotrexate—germ cell cancer	6.95e-05	0.000942	CcSEcCtD
Lamivudine—Dizziness—Etoposide—germ cell cancer	6.95e-05	0.000941	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—germ cell cancer	6.93e-05	0.000939	CcSEcCtD
Lamivudine—ABCB1—gonad—germ cell cancer	6.92e-05	0.00109	CbGeAlD
Lamivudine—Leukopenia—Methotrexate—germ cell cancer	6.9e-05	0.000935	CcSEcCtD
Lamivudine—ABCB1—uterus—germ cell cancer	6.88e-05	0.00108	CbGeAlD
Lamivudine—Nausea—Cisplatin—germ cell cancer	6.81e-05	0.000923	CcSEcCtD
Lamivudine—ABCC4—Hemostasis—CD9—germ cell cancer	6.76e-05	0.00193	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.76e-05	0.00193	CbGpPWpGaD
Lamivudine—ABCB1—pituitary gland—germ cell cancer	6.76e-05	0.00106	CbGeAlD
Lamivudine—Cough—Methotrexate—germ cell cancer	6.73e-05	0.000912	CcSEcCtD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.69e-05	0.00191	CbGpPWpGaD
Lamivudine—Convulsion—Methotrexate—germ cell cancer	6.68e-05	0.000905	CcSEcCtD
Lamivudine—Vomiting—Etoposide—germ cell cancer	6.68e-05	0.000905	CcSEcCtD
Lamivudine—Rash—Etoposide—germ cell cancer	6.62e-05	0.000897	CcSEcCtD
Lamivudine—Dermatitis—Etoposide—germ cell cancer	6.62e-05	0.000897	CcSEcCtD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	6.6e-05	0.00188	CbGpPWpGaD
Lamivudine—PGK1—Disease—KITLG—germ cell cancer	6.59e-05	0.00188	CbGpPWpGaD
Lamivudine—Headache—Etoposide—germ cell cancer	6.58e-05	0.000892	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—germ cell cancer	6.56e-05	0.000889	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—germ cell cancer	6.56e-05	0.000889	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—germ cell cancer	6.56e-05	0.000889	CcSEcCtD
Lamivudine—ABCB1—medulla oblongata—germ cell cancer	6.52e-05	0.00103	CbGeAlD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	6.52e-05	0.000883	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—germ cell cancer	6.48e-05	0.000879	CcSEcCtD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.41e-05	0.00183	CbGpPWpGaD
Lamivudine—Confusional state—Methotrexate—germ cell cancer	6.34e-05	0.00086	CcSEcCtD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.33e-05	0.00181	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.32e-05	0.0018	CbGpPWpGaD
Lamivudine—Anaphylactic shock—Methotrexate—germ cell cancer	6.29e-05	0.000853	CcSEcCtD
Lamivudine—Infection—Methotrexate—germ cell cancer	6.25e-05	0.000847	CcSEcCtD
Lamivudine—Nausea—Etoposide—germ cell cancer	6.24e-05	0.000845	CcSEcCtD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.23e-05	0.00178	CbGpPWpGaD
Lamivudine—Nervous system disorder—Methotrexate—germ cell cancer	6.17e-05	0.000836	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—germ cell cancer	6.16e-05	0.000835	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—germ cell cancer	6.11e-05	0.000828	CcSEcCtD
Lamivudine—Hyperhidrosis—Methotrexate—germ cell cancer	6.08e-05	0.000824	CcSEcCtD
Lamivudine—NME1—Metabolism—CRABP1—germ cell cancer	6.06e-05	0.00173	CbGpPWpGaD
Lamivudine—ABCB1—adrenal gland—germ cell cancer	6.04e-05	0.000951	CbGeAlD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.03e-05	0.00172	CbGpPWpGaD
Lamivudine—Anorexia—Methotrexate—germ cell cancer	6e-05	0.000813	CcSEcCtD
Lamivudine—ABCB1—midbrain—germ cell cancer	5.96e-05	0.000939	CbGeAlD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.94e-05	0.00169	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	5.9e-05	0.00168	CbGpPWpGaD
Lamivudine—Hypotension—Methotrexate—germ cell cancer	5.88e-05	0.000797	CcSEcCtD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	5.86e-05	0.00167	CbGpPWpGaD
Lamivudine—ABCB1—bone marrow—germ cell cancer	5.84e-05	0.00092	CbGeAlD
Lamivudine—ABCB1—spinal cord—germ cell cancer	5.81e-05	0.000916	CbGeAlD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	5.75e-05	0.00164	CbGpPWpGaD
Lamivudine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	5.73e-05	0.000777	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—germ cell cancer	5.69e-05	0.000771	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—germ cell cancer	5.65e-05	0.000766	CcSEcCtD
Lamivudine—ABCB1—female gonad—germ cell cancer	5.63e-05	0.000887	CbGeAlD
Lamivudine—Dyspnoea—Methotrexate—germ cell cancer	5.61e-05	0.00076	CcSEcCtD
Lamivudine—Somnolence—Methotrexate—germ cell cancer	5.59e-05	0.000758	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—germ cell cancer	5.54e-05	0.00075	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—germ cell cancer	5.47e-05	0.000741	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Methotrexate—germ cell cancer	5.43e-05	0.000736	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—germ cell cancer	5.42e-05	0.000735	CcSEcCtD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.41e-05	0.00154	CbGpPWpGaD
Lamivudine—Pain—Methotrexate—germ cell cancer	5.38e-05	0.000729	CcSEcCtD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.25e-05	0.0015	CbGpPWpGaD
Lamivudine—ABCB1—endocrine gland—germ cell cancer	5.23e-05	0.000825	CbGeAlD
Lamivudine—Feeling abnormal—Methotrexate—germ cell cancer	5.18e-05	0.000703	CcSEcCtD
Lamivudine—DCK—Metabolism—SLC2A3—germ cell cancer	5.17e-05	0.00148	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.17e-05	0.00147	CbGpPWpGaD
Lamivudine—ABCB1—head—germ cell cancer	5.17e-05	0.000814	CbGeAlD
Lamivudine—Gastrointestinal pain—Methotrexate—germ cell cancer	5.14e-05	0.000697	CcSEcCtD
Lamivudine—DCK—Metabolism—SLC22A3—germ cell cancer	5.1e-05	0.00145	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.08e-05	0.00145	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.02e-05	0.00143	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.01e-05	0.00143	CbGpPWpGaD
Lamivudine—Urticaria—Methotrexate—germ cell cancer	5e-05	0.000677	CcSEcCtD
Lamivudine—ABCB1—testis—germ cell cancer	4.99e-05	0.000787	CbGeAlD
Lamivudine—Abdominal pain—Methotrexate—germ cell cancer	4.97e-05	0.000674	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—germ cell cancer	4.97e-05	0.000674	CcSEcCtD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.95e-05	0.00141	CbGpPWpGaD
Lamivudine—PGK1—Disease—FGFR3—germ cell cancer	4.9e-05	0.0014	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.76e-05	0.00136	CbGpPWpGaD
Lamivudine—Hypersensitivity—Methotrexate—germ cell cancer	4.64e-05	0.000628	CcSEcCtD
Lamivudine—ABCB1—cerebellum—germ cell cancer	4.61e-05	0.000726	CbGeAlD
Lamivudine—Asthenia—Methotrexate—germ cell cancer	4.51e-05	0.000612	CcSEcCtD
Lamivudine—PGK1—Disease—KIT—germ cell cancer	4.5e-05	0.00128	CbGpPWpGaD
Lamivudine—Pruritus—Methotrexate—germ cell cancer	4.45e-05	0.000603	CcSEcCtD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.42e-05	0.00126	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.37e-05	0.00125	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.35e-05	0.00124	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.31e-05	0.00123	CbGpPWpGaD
Lamivudine—Diarrhoea—Methotrexate—germ cell cancer	4.3e-05	0.000583	CcSEcCtD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.24e-05	0.00121	CbGpPWpGaD
Lamivudine—Dizziness—Methotrexate—germ cell cancer	4.16e-05	0.000564	CcSEcCtD
Lamivudine—DCK—Metabolism—CRABP1—germ cell cancer	4.15e-05	0.00118	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.08e-05	0.00116	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.02e-05	0.00115	CbGpPWpGaD
Lamivudine—Vomiting—Methotrexate—germ cell cancer	4e-05	0.000542	CcSEcCtD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.97e-05	0.00113	CbGpPWpGaD
Lamivudine—Rash—Methotrexate—germ cell cancer	3.97e-05	0.000538	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—germ cell cancer	3.96e-05	0.000537	CcSEcCtD
Lamivudine—Headache—Methotrexate—germ cell cancer	3.94e-05	0.000534	CcSEcCtD
Lamivudine—ABCB1—brain—germ cell cancer	3.74e-05	0.00059	CbGeAlD
Lamivudine—Nausea—Methotrexate—germ cell cancer	3.74e-05	0.000506	CcSEcCtD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.7e-05	0.00106	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.65e-05	0.00104	CbGpPWpGaD
Lamivudine—ABCB1—lymph node—germ cell cancer	3.62e-05	0.00057	CbGeAlD
Lamivudine—ABCC4—Ectoderm Differentiation—MYC—germ cell cancer	3.49e-05	0.000995	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC2A3—germ cell cancer	3.27e-05	0.000932	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—AVP—germ cell cancer	3.22e-05	0.000918	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	3.17e-05	0.000903	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC2A3—germ cell cancer	3e-05	0.000857	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC22A3—germ cell cancer	2.96e-05	0.000844	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—AVP—germ cell cancer	2.96e-05	0.000843	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SLC2A3—germ cell cancer	2.81e-05	0.000801	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—AVP—germ cell cancer	2.78e-05	0.000793	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CRABP1—germ cell cancer	2.62e-05	0.000748	CbGpPWpGaD
Lamivudine—PGK1—Disease—MYC—germ cell cancer	2.48e-05	0.000706	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	2.42e-05	0.00069	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CRABP1—germ cell cancer	2.41e-05	0.000688	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.39e-05	0.000682	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.35e-05	0.000672	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC2A3—germ cell cancer	2.35e-05	0.000671	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.34e-05	0.000669	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC22A3—germ cell cancer	2.32e-05	0.000661	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.32e-05	0.000661	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC2A3—germ cell cancer	2.07e-05	0.000591	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC2A3—germ cell cancer	2.05e-05	0.000584	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC22A3—germ cell cancer	2.04e-05	0.000582	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.04e-05	0.000582	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC22A3—germ cell cancer	2.02e-05	0.000576	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.02e-05	0.000576	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—germ cell cancer	1.94e-05	0.000555	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A3—germ cell cancer	1.91e-05	0.000545	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CRABP1—germ cell cancer	1.89e-05	0.000539	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC22A3—germ cell cancer	1.88e-05	0.000537	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.88e-05	0.000536	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CRABP1—germ cell cancer	1.66e-05	0.000474	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CRABP1—germ cell cancer	1.65e-05	0.000469	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF4—germ cell cancer	1.61e-05	0.00046	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CRABP1—germ cell cancer	1.53e-05	0.000437	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.48e-05	0.000422	CbGpPWpGaD
Lamivudine—ABCC1—Disease—H2AFZ—germ cell cancer	1.44e-05	0.000411	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.38e-05	0.000393	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KITLG—germ cell cancer	1.33e-05	0.000378	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—germ cell cancer	1.13e-05	0.000323	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.12e-05	0.000319	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.1e-05	0.000315	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.1e-05	0.000314	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.07e-05	0.000304	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—germ cell cancer	1.06e-05	0.000301	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—germ cell cancer	1.01e-05	0.000289	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR3—germ cell cancer	9.85e-06	0.000281	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—germ cell cancer	9.69e-06	0.000276	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KIT—germ cell cancer	9.05e-06	0.000258	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CRABP1—germ cell cancer	8.99e-06	0.000256	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.76e-06	0.00025	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—germ cell cancer	4.98e-06	0.000142	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—germ cell cancer	3.91e-06	0.000112	CbGpPWpGaD
